Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

LONDON BRIEFING: UK inflation rises; Barratt cuts completions outlook

16th Sep 2026 07:59

(Alliance News) - UK inflation accelerates to 3.1% in August as higher fuel costs drive prices higher. Barratt Redrow reports a rise in annual pretax profit but lowers its home completions guidance, while Babcock says trading is in line with expectations and leaves its outlook unchanged. Read More

LONDON BROKER RATINGS: Berenberg likes GSK; Deutsche Bank lifts Astra

15th Sep 2026 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

GSK agrees up to USD750 million deal for blood cancer-targeting drug

15th Sep 2026 09:34

(Alliance News) - GSK PLC on Tuesday said it has agreed to buy "a potential best-in-class" T cell-engager aimed at treating multiple myeloma from China-based clinical-stage biotechnology company Chimagen Biosciences for up to USD750 million. Read More

LONDON BRIEFING: GSK in T-cell deal; Kier puts brakes on Property arm

15th Sep 2026 07:58

(Alliance News) - GSK says it has struck a deal to acquire a promising T-cell asset, while Kier Group's annual profit beat consensus. Read More

LONDON MARKET CLOSE: FTSE 100 outperforms as AI worry hits Wall Street

14th Sep 2026 17:10

(Alliance News) - Stock prices in London closed mixed on Monday, with Middle East tensions, AI slowdown fears and caution ahead of a flurry of central bank meetings keeping investors on their toes. Read More

WINNERS & LOSERS: GlobalData sinks; Sage rises on AI safety fear

14th Sep 2026 10:07

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday. Read More

GSK plans expanded US submission for Jideytro after positive results

14th Sep 2026 09:24

(Alliance News) - GSK PLC on Monday reported positive findings from a phase I/II trial evaluating zidesamtinib in patients with non-small cell lung cancer who have not received previous treatment. Read More

GSK gets Japan approval for prefilled Shingrix vaccine

10th Sep 2026 09:26

(Alliance News) - GSK PLC on Thursday said its Shingrix shingles vaccine has been approved by Japan's Ministry of Health, Labour & Welfare. Read More

LONDON BROKER RATINGS: RBC prefers Astra to GSK; HSBC cuts Burberry

9th Sep 2026 09:04

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON MARKET CLOSE: FTSE 100 slips as Bailey flags inflation risks

8th Sep 2026 17:10

(Alliance News) - Stock prices in London closed lower on Tuesday, as Bank of England Governor Andrew Bailey warned of upside inflation risks amid elevated energy prices, while Computacenter reversed an early rally to finish at the bottom of the FTSE 100. Read More

LONDON BROKER RATINGS: Jefferies raises Autotrader and Rightmove

8th Sep 2026 09:08

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON MARKET MIDDAY: FTSE 100 edges higher; oil rises above USD97

3rd Sep 2026 12:10

(Alliance News) - Stock prices in London were higher at midday on Thursday, as gains for telecom stocks helped the FTSE 100 edge into positive territory, while investors digested stronger UK services activity and rising inflationary pressures in Europe. Read More

WINNERS & LOSERS: Hutchmed pens GSK deal; Gem Diamonds back in profit

3rd Sep 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More

Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830

3rd Sep 2026 10:22

(Alliance News) - Hutchmed China PLC on Thursday announced that its subsidiary, Hutchmed Ltd, has entered into an exclusive development licence agreement with a subsidiary of GSK PLC. Read More

LONDON BRIEFING: LondonMetric investments; Jet2 eyes Main Market move

3rd Sep 2026 07:56

(Alliance News) - M&G swings to a first-half pretax loss attributable to equity holders as short-term investment fluctuations weigh on statutory results, while LondonMetric Property announces GBP105 million of investment activity. Elsewhere, Jet2 says trading remains strong and announces plans to move from AIM to London's Main Market. Read More

GSK advances mRNA flu vaccine to phase 3 after positive results

1st Sep 2026 11:23

(Alliance News) - GSK PLC on Tuesday said a phase 2 probe of its mRNA flu vaccine candidate showed positive results and that phase 3 trials will start this month. Read More

LONDON BRIEFING: UK house prices subdued; Bunzl lifts outlook

1st Sep 2026 07:58

(Alliance News) - UK house price growth remains subdued in August despite a modest monthly recovery. Bunzl upgrades its full-year outlook and announces a GBP500 million share buyback, while Bodycote and Gamma Communications accept takeover offers. Read More

LONDON MARKET CLOSE: FTSE down as inflation fear offsets Nvidia lift

27th Aug 2026 17:01

(Alliance News) - The FTSE 100 faltered on Thursday, despite technology focused stocks getting a boost from Nvidia, with investors wary ahead of Kevin Warsh's speech at Jackson Hole. Read More

LONDON MARKET CLOSE: FTSE 100 outperforms as oil price heads lower

24th Aug 2026 17:04

(Alliance News) - The FTSE 100 closed higher in London on Monday, outperforming European peers, as oil prices edged lower and investors looked ahead to key events in the US later this week. Read More

IN BRIEF: GSK US President sells shares worth USD2.3 million

24th Aug 2026 16:50

GSK PLC - London-based pharmaceutical firm - President of the US business Maya Martinez-Davis sells 3,916 American depository receipts at an average price of USD52.14 each, worth approximately GBP204,180 in total, on Thursday in New York. On Friday, Martinez-Davis sells 40,481 ADRs, also at an average USD52.14 each, worth about USD2.1 million. Read More

FTSE 100 Latest
Value10,659.13
Change-157.01